Hyperbaric help for cancer patients
THE James Paget University Hospital is to be one of the first in the country to offer on the NHS a pioneering treatment for cancer patients suffering unpleasant side-effects from radiotherapy.
THE James Paget University Hospital is to be one of the first in the country to offer on the NHS a pioneering treatment for cancer patients suffering unpleasant side-effects from radiotherapy.
The treatment has involved doctors finding an exciting new use for a piece of equipment normally used to treat North Sea divers with the bends.
A study in the US has shown that cancer patients with a range of serious side-effects from radiotherapy can benefit from treatment in a hyperbaric chamber, which delivers pure oxygen to them under higher-than-normal air pressure.
The convincing results have convinced NHS funders to pay for the therapy - costing up to �6,000 per patient - and the JPH can offer it as the only hospital in the East of England to have a chamber.
You may also want to watch:
Dr Pieter Bothma, the chamber's lead clinician, said: “The hospital was about to take part in a national trial of the treatment, but we decided to pull out after the results of the US study.
“A trial would have involved one group of our patients not receiving the treatment and we did not want that in light of its proven effectiveness.”
Most Read
- 1 Man charged with having more than 220,000 indecent images of children
- 2 Seaside cafe gets permission to sell alcohol
- 3 What's opening in Great Yarmouth from May 17?
- 4 Tributes to high street mechanic known as a 'local legend'
- 5 Police break up house party with 28 people crammed into flat
- 6 Man arrested after police find 200 cannabis plants in building
- 7 Goodbye number 12 - Send off to dedicated 4x4 response member
- 8 Buy a B&B as nine for sale in 'boom year' for budget hotels
- 9 Seafront Empire re-opening as music and street food venue
- 10 Three adorable abandoned day-old kittens adopted by stray
The therapy has proved effective in helping patients suffering side-effects from radiotherapy treatment for tumours in the abdomen and pelvic area, such as prostate cancer in men and cancer of the uterus and ovaries in women.
Dr Bothma said the side-effects were the result of radiation damaging normal cells as well as killing the cancer cells.
The symptoms, which often did not show up until some time after treatment had been completed, included pain, bleeding and frequent bowel movements. Patients could also pass blood and become anaemic.
In some cases, it prevented their gut taking up nutrients from food and led them to lose weight.
Dr Bothma said: “Radiotherapy treatment is improving all the time and it is only a small percentage of people who suffer side-effects, but we believe that we will be able to help about 10 patients a year.”
The JPH took delivery of its �260,000 chamber in December 2007 through a private/public partnership involving London Hyperbaric and Wound Healing Centres.
As well as helping bends victims, it is used to treat patients with conditions such as difficult-to-heal wounds and circulation problems resulting from diabetes.
Dr Bothma said the potential use of the chamber in helping cancer patients after radiation had been understood for a long time, but it was only the results of the US study that had led to the release of funding for NHS patients.
